Acquisition by Abigail Jenkins of 1000000 shares of Gamida Cell at 2.22 subject to Rule 16b-3

GMDADelisted Stock  USD 1.40  0.09  6.04%   
About 62% of Gamida Cell's investor base is looking to short. The analysis of current outlook of investing in Gamida Cell suggests that many traders are alarmed regarding Gamida Cell's prospects. The current market sentiment, together with Gamida Cell's historical and current headlines, can help investors time the market. In addition, many technical investors use Gamida Cell stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Gamida Cell Director, Officer: President And Ceo. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at finance.yahoo.com
Yahoo News
  
Acquisition of 1000000 employee share option (right to buy) at 2.22 of Gamida Cell by Abigail Jenkins on 22nd of March 2024. This event was filed by Gamida Cell with SEC on 2023-10-19. SEC Form: Changes in beneficial ownership

Gamida Cell Fundamental Analysis

We analyze Gamida Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gamida Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gamida Cell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Short Ratio

Short Ratio Comparative Analysis

Gamida Cell is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Gamida Cell Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Gamida Cell stock to make a market-neutral strategy. Peer analysis of Gamida Cell could also be used in its relative valuation, which is a method of valuing Gamida Cell by comparing valuation metrics with similar companies.

Peers

Gamida Cell Related Equities

XFORX4 Pharmaceuticals   11.43   
0%
100.0%
MCRBSeres Therapeutics   6.52   
0%
57.0%
BLRXBioLineRx   3.45   
0%
30.0%
PLXProtalix Biotherapeutics   1.78   
0%
15.0%
HOOKHookipa Pharma   1.61   
0%
14.0%
DAWNDay One   1.53   
0%
13.0%
ARDXArdelyx   0.35   
3.0%
0%
INZYInozyme Pharma   0.37   
3.0%
0%
IOVAIovance Biotherapeutics   0.85   
7.0%
0%
IBRXImmunitybio   1.18   
10.0%
0%
TERNTerns Pharmaceuticals   1.58   
13.0%
0%
LXRXLexicon Pharmaceuticals   2.44   
21.0%
0%
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Consideration for investing in Gamida Stock

If you are still planning to invest in Gamida Cell check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gamida Cell's history and understand the potential risks before investing.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities